Mark T Iwicki is of Akero Therapeutics, Inc.. Currently has a direct ownership of 9,398 shares of AKRO, which is worth approximately $514,540. The most recent transaction as insider was on Jun 03, 2025, when has been sold 9,398 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.4K
n/a 3M change
n/a 12M change
Total Value Held $514,540

Mark T Iwicki Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 03 2025
BUY
Grant, award, or other acquisition
-
9,398 Added 50.0%
9,398 Common Stock

Also insider at

KALA
Kala Pharmaceuticals, Inc. Healthcare
PULM
Pulmatrix, Inc. Healthcare
MRUS
Merus N.V. Healthcare
AVTE
Aerovate Therapeutics, Inc. Healthcare
IKT
Inhibikase Therapeutics, Inc. Healthcare
THRD
Third Harmonic Bio, Inc. Healthcare
FIXX
Homology Medicines, Inc. Healthcare
MTI

Mark T Iwicki

Utretcht, P7

Track Institutional and Insider Activities on AKRO

Follow Akero Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKRO shares.

Notify only if

Insider Trading

Get notified when an Akero Therapeutics, Inc. insider buys or sells AKRO shares.

Notify only if

News

Receive news related to Akero Therapeutics, Inc.

Track Activities on AKRO